Metabolic Effects of Empagliflozin in Heart Failure A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)
Research output: Contribution to journal › Letter › Research › peer-review
| Original language | English |
|---|---|
| Journal | Circulation |
| Volume | 143 |
| Issue number | 22 |
| Pages (from-to) | 2208-2210 |
| Number of pages | 3 |
| ISSN | 0009-7322 |
| DOIs | |
| Publication status | Published - 2021 |
- body composition, diabetes mellitus, type 2, empagliflozin, heart failure, insulin resistance, sodium-glucose transporter 2 inhibitors, REDUCED EJECTION FRACTION
Research areas
ID: 271613089